Biodefense and Emerging Infectious Diseases News and Events
News Releases and Statements
Dec. 20, 2011
Chikungunya Vaccine Trial Begins Enrollment
Oct. 19, 2011
Antibody Treatment Protects Monkeys from Hendra Virus Disease
Oct. 13, 2011
NIH Funds Development of New Broad-Spectrum Therapeutics
Oct. 7, 2011
Experimental Vaccine Protects Monkeys from Blinding Trachoma
Oct. 4, 2011
Priming with DNA Vaccine Makes Avian Flu Vaccine Work Better
Sept. 6, 2011
Media Availability: New TB Vaccine Approach Shows Promise in Mice
Aug. 16, 2011
Any Prime-Boost Mix of Injected or Spray Flu Vaccine Shields Toddlers
Aug. 11, 2011
Media Availability: Scientists Explain Unique Activity of TB Drug Pyrazinamide
May 9, 2011
Media Availability: NIH Study Describes Fast, Sensitive Blood Test for Human Prion Disease
April 27, 2011
Leprosy in U.S. May Be Transmitted by Armadillos, Study Finds
April 13, 2011
Media Availability: Increased Prevention Efforts May Not Reduce Spread of Hospital-Based Bacteria
Feb. 8, 2011
Media Availability: NIH, CDC and PAHO To Hold Scientific Meeting in Puerto Rico on Dengue in the Americas
Jan. 25, 2011
Media Availability: Collaboration Fuels Promising New Approach to a TB Vaccine
Jan. 12, 2011
Web Bulletin: Antibodies Identified after 2009 H1N1 Infection Neutralize Multiple Flu Virus Strains
Nov. 17, 2010
NIH Scientists Show how Anthrax Bacteria Impair Immune Response
Oct. 7, 2010
NIH Funds Advanced Development of Three Biodefense Vaccines
Aug. 19, 2010
NIH Renews Major Research Program to Develop Medical Countermeasures Against Radiological and Nuclear Threats
May 20, 2010
Experimental Vaccine Protects Monkeys from New Ebola Virus
Nov. 12, 2009
NIAID Announces New Award to Study the Effects of Radiation and Aging on the Human Immune System
Nov. 4, 2009
NIAID Announces New Human Immunology Research Awards to Help Fight Emerging Infectious Diseases
June 8, 2009
NIAID Renews Funding for National Emerging Infectious Diseases Research Network
Oct. 5, 2007
HHS Release: HHS Awards Contracts for Advanced Development of New Medical Countermeasures
July 2, 2007
Human Antibodies that Block Human and Animal SARS Viruses Identified
June 6, 2007
NIAID Media Availability: NIAID Releases MDR/XDR Tuberculosis Research Agenda
April 18, 2007
HHS Releases Plan for Development and Purchase of Medical Countermeasures
March 8, 2007
HHS Launches New Online Toolkit for Medical Responses to Radiation Emergencies
Dec. 13, 2006
Molecular Structure Reveals How Botulinum Toxin Attaches to Nerve Cells, May Lead to New Therapeutics
Sept. 25, 2006
NIAID Awards $4 Million to Develop Anti-Radiation Treatments
July 12, 2006
New NIAID Program Aims to Model Immune Responses and Key Infectious Diseases
May 3, 2006
NIH Dedicates the C.W. Bill Young Center for Biodefense and Emerging Infectious Diseases
April 26, 2006
Vaccine Given Post-Exposure Protects Monkeys Against Deadly Marburg Virus
April 23, 2006
Scientists Design Potent Anthrax Toxin Inhibitor
Jan. 23, 2006
Mice Studies Illustrate Potential of Chimp/Human Antibodies to Protect Against Smallpox
Oct. 12, 2005
NIAID Awards $47 Million in New Effort to Develop Medical Countermeasures Against Radiological and Nuclear Threats
Oct. 3, 2005
Large Tularemia Vaccine Contracts Among New NIAID Biodefense Awards
July 6, 2005
Scientists Discover How Nipah Virus Enters Cells
June 27, 2005
Cancer Drug Slows Poxvirus in Mice
June 1, 2005
New NIAID Grants Strengthen National Biodefense and Emerging Infectious Diseases Research Network
Feb. 1, 2005
New Way To Block Pox Shows Promise In Lab Study
Nov. 1, 2004
NIAID Launches Program to Improve Medical Tools Against Emerging Infectious Diseases
Oct. 12, 2004
New Study on Smallpox in Monkeys Reveals Tactics of a Killer
Oct. 7, 2004
HHS Awards $232 Million in Biodefense Contracts for Vaccine Development
July 4, 2004
3-D Structure of Anthrax Toxin Complex Solved
May 19, 2004
NIAID Forms Network to Tackle Potentially Fatal Reaction to Smallpox Vaccine
March 24, 2004
Mouse Model Mimics Real-World Plague Infection
March 10, 2004
Effectiveness of Safer Smallpox Vaccine Demonstrated Against Monkeypox
Nov. 18, 2003
NIAID Ebola Vaccine Enters Human Trial
Sept. 30, 2003
NIAID Funds Construction of Biosafety Laboratories
Sept. 29, 2003
NIAID Reports 'Tremendous Progress' in Biodefense Research
Sept. 17, 2003
$85 Million Awarded for Research on Human Immunity and Biodefense
Sept. 4, 2003
HHS Announces New Regional Centers for Biodefense Research
Sept. 2, 2003
Mouse Study Gives New View of Anthrax Toxin
Aug. 6, 2003
Fast-Acting Ebola Vaccine Protects Monkeys
April 30, 2003
Anthrax Genome Decoded
Feb. 25, 2003
HHS Announces Contracts To Develop Safer Smallpox Vaccines
Jan. 8, 2003
Powerful Technologies Probe Innate Immunity
Oct. 17, 2002
Dr. Marshall Bloom Named Associate Director of Rocky Mt. Laboratories
Oct. 15, 2002
USAMRIID-NIAID Announce Research Partnership at Fort Detrick
Oct. 3, 2002
HHS Announces Contracts for Developing a New Anthrax Vaccine
June 11, 2002
NIAID Expands Vaccine Testing Network
May 9, 2002
Researchers Unravel Anthrax Genome
April 25, 2002
Single Gene Leap Led to Flea-Borne Transmission of Plague Bacterium
March 28, 2002
NIAID Study Results Support Diluting Smallpox Vaccine Stockpile to Stretch Supply
March 14, 2002
NIAID Unveils Biodefense Research Agenda
Dec. 6, 2001
Dec. 6, 2001
HHS Accelerates Bioterrorism Research
Oct. 23, 2001
NIAID-supported Anthrax studies appearing in the journal Nature
Nov. 29, 2000
Novel Vaccine Protects Monkeys from Ebola Infection
back to top